Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Incannex Healthcare announced positive results from a pharmacokinetics and safety study of IHL-42X, its oral fixed-dose combination of acetazolamide and dronabinol, aimed at treating obstructive sleep ...

Incannex Healthcare Inc. announced positive findings from its IHL-42X study for treating obstructive sleep apnea (OSA), paving the way for a future FDA 505(b)(2) new drug application. The company ...

Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by ...

The American Academy of Sleep Medicine has indicated that an estimated 26 percent of adults between the ages of 30 and 70 years have sleep apnea. (Photo: Getty) You could say that it’s difficult to ...

Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...

LunAIRo, Apnimed's second Phase 3 trial of AD109, met its primary endpoint, demonstrating a reduction in the Apnea-Hypopnea Index (AHI) from baseline at 26 weeks (p<0.001 vs. placebo); no serious ...

What impact can cannabis have for sleep apnea patients? This is what a recent report from the Office of Cannabis Management hopes to address as a team of researchers investigated the pros and cons of ...